Reminder: CDTRP Research Innovation Grant (13 February 2019)

The primary objective of the CDTRP Research Innovation Grant competition is to support new peer-reviewed pilot research projects that align with CDTRP’s One-Transplant-for-Life vision, which is to fulfill every donor opportunity and turn transplant into a cure. These projects must be new stand-alone studies that align with one (1) of five (5) themes of the CDTRP and should be used to generate preliminary data to support further investigation. The five (5) CDTRP Themes are:

  1. Create a culture of donation
  2. Inform universal practices for donation
  3. Engineer and allocate a better graft
  4. Tailor an optimal immune system for each patient
  5. Restore long-term health

Grant recipients are expected to integrate their proposed study within the CDTRP research structure.

The total value of the competition is $510,000 and each grant is a total of $30,000 CDN each, enough to support 17 grants.

Of the $510,000, we will support grants in the following strategic areas:

  • six (6) grants of $30,000 CDN/each to support new research that addresses the One-Transplant-for-Life vision and aligns with one of the 5 Themes. These will be provided through the CDTRP Research Innovation Grant competition over an 18-month performance period with funding provided by Astellas Pharma Canada, Inc.;
  • two (2) grants of $30,000 CDN/each to support new research related to kidney donation and/or transplantation that addresses the One-Transplant-for-Life vision and aligns with one of the 5 Themes. These will be provided through the CDTRP KFOC Research Innovation Grant competition over an 18-month performance period with funding provided by the Kidney Foundation of Canada
  • one (1) grant of $30,000 CDN to support new research in lung transplantation that addresses the unique needs of the cystic fibrosis community, including: improving long-term health outcomes for cystic fibrosis transplant recipients;  transplant immunology and infection in cystic fibrosis; and addressing post-transplant health and social challenges for those living with cystic fibrosis (e.g. long-term exposure to high doses of anti-rejection medications, mental health, support with respect to social re-integration). This will be provided through the CDTRP CF Canada Research Innovation Grant competition over an 18-month performance period with funding provided by Cystic Fibrosis Canada;
  • two (2) grants of $30,000 CDN/each to support new research related to pediatric transplantation that addresses the One-Transplant-for-Life vision and aligns with one of the 5 Themes. One of these projects must be based in British Columbia and the other must be based in Edmonton, Alberta.  The Edmonton project must also be focused on pediatric heart transplantation.  While not required, we strongly encourage the community to submit one combined application that includes both a Vancouver and Edmonton component that will work together to address issues related to pediatric transplantation. These will be provided through the CDTRP Addison Fund Research Innovation Grant competition and the CDTRP Big Gifts for Little Lives Research Innovation Grant competition respectively over an 18-month performance period;
  • The Alberta Transplant Innovation Fund (ATIF) will provide four (4) additional grants of $30,000 CAD/each to the top ranked Alberta-based researchers through the CDTRP ATIF Research Innovation Grant competition over an 18-month performance period. The ATIF receives funding from the Alberta Ministry of Economic Development and Trade, the University Hospital Foundation, and Astellas Pharma Canada;
  • The UHN-MOT will provide two (2) additional grants of $30,000 CDN/each to the top ranked unfunded UHN researchers through the CDTRP UHN Research Innovation Grant competition over an 18-month performance period.

Each grant will be awarded to the successful applicant(s) via the Primary Applicant’s institution.
Click here for full details and to download an application form.

Application Deadline: 13 February 2019
Notification Date: 7 May 2019
Funding Start Date: 20 May 2019, or upon confirmation of REB approval

Tags: , ,

%d bloggers like this: